Feb 012017
 

By Talent4Boards Team

Talent4Boards - Great Talent builds Great Boards

– USA, OR – VisCardia Inc, a privately held medical device developer, announced today it has completed series B financing and simultaneously obtained assets and technology rights from Inovise Medical, Inc., with a combined aggregate value of $12.5M, to continue development of its proprietary implantable heart failure therapy device.… => Read more

VisCardia adds Dr Michael Mirro to Board along with a financing led by Kinetic Capital Partners and Assets Transfer for total $12.5m

From:: VisCardia adds Dr Michael Mirro to Board along with a financing led by Kinetic Capital Partners and Assets Transfer for total $12.5m

Sorry, the comment form is closed at this time.

%d bloggers like this: